Elequin Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-99
| Closed | -$4.19K | – | 386 |
|
|
2024
Q1 | $4.19K | Buy |
99
+89
| +890% | +$3.76K | ﹤0.01% | 160 |
|
|
2023
Q4 | $424 | Sell |
10
-6
| -38% | -$254 | ﹤0.01% | 325 |
|
|
2023
Q3 | $349 | Sell |
16
-395
| -96% | -$8.62K | ﹤0.01% | 354 |
|
|
2023
Q2 | $13.1K | Buy |
+411
| New | +$13.1K | 0.01% | 274 |
|
|
2023
Q1 | – | Sell |
-922
| Closed | -$29.1K | – | 576 |
|
|
2022
Q4 | $29.1K | Buy |
+922
| New | +$29.1K | 0.01% | 356 |
|